Group One Trading
ARRY

Group One Trading’s Array Biopharma Inc ARRY Stock Holding History

Group One Trading’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-805,300
Closed -$37.3M – 5871
2019
Q2 		$37.3M Buy
805,300
+481,000
+148% +$13.5M 0.34% 32
2019
Q1 		$7.91M Sell
324,300
-51,900
-14% -$1.08M 0.09% 253
2018
Q4 		$5.36M Buy
376,200
+36,400
+11% +$552K 0.05% 479
2018
Q3 		$5.17M Sell
339,800
-62,600
-16% -$959K 0.04% 571
2018
Q2 		$6.75M Buy
402,400
+98,700
+32% +$1.57M 0.06% 398
2018
Q1 		$4.96M Sell
303,700
-373,800
-55% -$5.99M 0.05% 477
2017
Q4 		$8.67M Buy
677,500
+103,500
+18% +$1.18M 0.06% 392
2017
Q3 		$7.06M Buy
574,000
+317,000
+123% +$2.94M 0.06% 382
2017
Q2 		$2.15M Sell
257,000
-160,700
-38% -$1.31M 0.02% 914
2017
Q1 		$3.73M Buy
417,700
+92,300
+28% +$982K 0.04% 531
2016
Q4 		$2.86M Buy
325,400
+29,500
+10% +$217K 0.03% 721
2016
Q3 		$2M Buy
295,900
+216,100
+271% +$836K 0.02% 852
2016
Q2 		$284K Sell
79,800
-217,300
-73% -$708K ﹤0.01% 2162
2016
Q1 		$876K Buy
297,100
+22,900
+8% +$68.6K 0.01% 1280
2015
Q4 		$1.16M Sell
274,200
-231,700
-46% -$1.06M 0.01% 1219
2015
Q3 		$2.31M Sell
505,900
-314,900
-38% -$1.87M 0.03% 703
2015
Q2 		$5.92M Sell
820,800
-44,200
-5% -$326K 0.08% 264
2015
Q1 		$6.38M Buy
865,000
+719,800
+496% +$5.12M 0.1% 189
2014
Q4 		$687K Buy
145,200
+9,400
+7% +$37.2K 0.01% 1320
2014
Q3 		$485K Buy
135,800
+75,000
+123% +$296K 0.01% 1652
2014
Q2 		$277K Sell
60,800
-152,800
-72% -$632K ﹤0.01% 2121
2014
Q1 		$1M Buy
213,600
+206,400
+2,867% +$1.04M 0.02% 1086
2013
Q4 		$36K Buy
7,200
+300
+4% +$1.63K ﹤0.01% 3870
2013
Q3 		$43K Buy
6,900
+5,400
+360% +$32.1K ﹤0.01% 3654
2013
Q2 		$7K Buy
+1,500
New +$8.07K ﹤0.01% 4598

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Group One Trading's ARRY Position: Q3 2017 in Review

Group One Trading sold out of Array Biopharma Inc (ARRY) in Q3 2017, closing a stake of 172,370 shares — an estimated $1.6M sold.

Group One Trading first reported a position in ARRY in Q2 2013 and held it in 11 quarters. The position peaked at $2.19M in Q1 2017. 184 funds tracked by Wall St. Rank hold ARRY as of Q3 2017.

  • Group One Trading reported no remaining Array Biopharma Inc position as of Q3 2017 after selling out during the quarter.
  • Group One Trading sold 172,370 Array Biopharma Inc shares in Q3 2017, an estimated $1.6M.
  • Group One Trading first reported a position in Array Biopharma Inc in Q2 2013 and held it in 11 quarters.
  • Group One Trading's Array Biopharma Inc position peaked at $2.19M in Q1 2017.
  • 184 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2017.

Based on Group One Trading's 13F filing for Q3 2017, filed 15 Nov 2017.